Skip to main content

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced that its Chief Executive Officer, Mark Velleca, M.D., Ph.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2025 in New York, NY. In addition, the company will host one-on-one meetings with investors on the same day.

Presentation details are as follows:

  • 4:20-4:50pm ET on Wednesday, June 4

The Webcast will be available at the start of the presentation on the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of the webcast will also be available and archived for 90 days following the event.

About Black Diamond Therapeutics

Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The Company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type mediated toxicities, and be brain penetrant to treat central nervous system disease. The Company is advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. For more information, please visit www.blackdiamondtherapeutics.com.

Contacts

For Investors:
investors@bdtx.com

For Media:
media@bdtx.com 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.99
-4.65 (-2.21%)
AAPL  271.32
-2.91 (-1.06%)
AMD  202.06
-8.80 (-4.17%)
BAC  52.13
+0.44 (0.85%)
GOOG  304.99
-8.04 (-2.57%)
META  654.72
+1.03 (0.16%)
MSFT  399.68
-0.92 (-0.23%)
NVDA  185.25
-10.31 (-5.27%)
ORCL  147.14
-0.75 (-0.51%)
TSLA  405.13
-12.27 (-2.94%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.